Calypso Medical Technologies Announces AIM Clinical Study for Prostate Cancer Patients

SEATTLE--(BUSINESS WIRE)--Calypso Medical announced the launch of the AIM Clinical Study (Assessing the Impact of Margin Reduction) using Calypso Medical’s GPS for the Body® technology for patients receiving radiation therapy for prostate cancer. The primary objectives of the study are to evaluate acute and chronic quality-of-life assessments and complications related to external beam radiation therapy in prostate cancer patients when the Calypso® 4D Localization System is used for managing motion.
MORE ON THIS TOPIC